Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?
Drug Discovery Today2016Vol. 22(1), pp. 85–96
Citations Over TimeTop 10% of 2016 papers
Danina Muntean, Paul M. Thompson, Alberico L. Catapano, Mariusz Stasiołek, Jarosław Fabiś, Paul Muntner, Maria-Corina Șerban, Maciej Banach
Related Papers
- → Pattern of statin use changes following media coverage of its side effects(2017)21 cited
- → Clinical Characteristics of Patients With Statin Discontinuation in Korea: A Nationwide Population-Based Study(2024)7 cited
- → Patient characteristics and statin discontinuation-related factors during treatment of hypercholesterolemia: an observational non-interventional study in patients with statin discontinuation (STAY study)(2015)11 cited
- → Preventable statin adverse reactions and therapy discontinuation. What can we learn from the spontaneous reporting system?(2018)13 cited
- → Discontinuation of Statin in Routine Care Settings: A Cohort Study(2013)2 cited